Avantor, which is owned by New Mountain Capital, has named Jean-Paul Mangeolle to its board of directors. Most recently, Mangeolle oversaw Merck Millipore’s process solutions business. Based in Center Valley, Penn., Avantor is a maker of high-performance chemistries.
CENTER VALLEY, PA–(Marketwired – Feb 19, 2014) – Avantor™ Performance Materials, a global manufacturer and supplier of high-performance chemistries, announces the appointment of Jean-Paul Mangeolle to its Board of Directors.
Mangeolle’s extensive experience includes a long career with Millipore, a global supplier of materials for the life science industry. Mangeolle served in various executive leadership roles within Millipore prior to and following its acquisition by Merck KGaA, Darmstadt. Most recently, Mangeolle oversaw Merck Millipore’s $1.3 billion Process Solutions business. Prior to that time, he served as president of the $1 billion Bioprocess Division of Millipore, and he at various times held senior roles within the company’s sales, marketing and supply chain functions. Mangeolle also served as vice president of worldwide operations for Mykrolis, a developer, manufacturer and supplier of liquid and gas delivery systems, components and consumables, which has since merged with Entegris.
“Jean-Paul offers a wealth of experience in the life science and specialty chemicals space,” says Richard White, chief operating officer and interim CEO of Avantor. “Our management team will benefit greatly from the unique insight that Jean-Paul has developed over his long career.”
“We are committed to finding the best and brightest minds to advise us as we further establish Avantor as a global leader in performance materials and chemistries,” says Raj Gupta, chairman of Avantor. “In Jean-Paul, we have found an ideal partner, with the industry knowledge and business acumen needed to support us as we pursue our aggressive growth objectives.”
“Avantor offers proven, respected brands that make us a strong player in the pharmaceutical and laboratory markets,” says Matt Holt, managing director of New Mountain Capital, which owns Avantor. “Jean-Paul’s experience in the life sciences field will be critical as we work to enhance our presence in this area, capture market share and meet our short- and long-term growth objectives.”
Mangeolle holds a Master of Science degree in Chemical Engineering from the University of Montpellier, France.
About Avantor™ Performance Materials
Based in Center Valley, PA (USA), Avantor Performance Materials manufactures and markets high-performance chemistries and materials around the world under several respected brand names, including the J.T.Baker®, Macron Fine Chemicals™, Rankem™, BeneSphera™, and POCH™ brands.
Avantor products are used in a wide range of industries. Our biomedical and life science solutions are used in pharmaceutical production, laboratory research for academic, industry and quality control, and in medical lab testing. Our electronics solutions are used in the manufacturing of semiconductors. For additional information please visit
About New Mountain Capital
New Mountain Capital is a New York‐based private equity firm that emphasizes business building and growth, rather than debt, as it pursues long‐term capital appreciation. The firm currently manages private and public equity funds with approximately $12 billion in aggregate capital commitments. New Mountain seeks out what it believes to be the highest-quality growth leaders in carefully selected industry sectors and then works intensively with management to build the value of these companies. For more information on New Mountain Capital, please visit